CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host an Analyst & Investor Day for its research analysts and institutional investors on Friday, June 17 at 8:30 a.m. (EDT) in New York City. Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, will host the event along with other key members of ARIAD senior management. The meeting will focus on ARIAD’s continued progress in its research and development programs and near-term commercial plans. Expert medical leaders in the fields of sarcomas, chronic myeloid leukemia and lung cancer will be featured speakers and discussants at the meeting.
